Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44,542,200
-
Total 13F shares
-
16,939,491
-
Share change
-
-490,721
-
Total reported value
-
$180,199,912
-
Put/Call ratio
-
283%
-
Price per share
-
$10.64
-
Number of holders
-
54
-
Value change
-
-$5,749,427
-
Number of buys
-
28
-
Number of sells
-
19
Institutional Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q1 2023
As of 31 Mar 2023,
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,939,491 shares.
The largest 10 holders included
Essex Woodlands Management, Inc., ORBIMED ADVISORS LLC, Opaleye Management Inc., AIGH Capital Management LLC, NEXT CENTURY GROWTH INVESTORS LLC, Velan Capital Investment Management LP, VANGUARD GROUP INC, Pentwater Capital Management LP, Worth Venture Partners, LLC, and PURA VIDA INVESTMENTS, LLC.
This page lists
54
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.